AirSculpt Technologies (AIRS) vs LifeMD (LFMD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
LifeMD (LFMD) has outperformed AirSculpt Technologies (AIRS) over the past year, losing 62.5% versus a loss of 83.9%. Over five years, LFMD leads with a -65.9% price change compared with -95.1% for AIRS. LifeMD is the larger company by market cap ($69.8 million vs $43.7 million), about 1.6 times the size.
LifeMD converts more of its revenue into profit, with a net margin of 7.4% versus -7.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AIRS | LFMD |
|---|---|---|
| Share price | $0.5907 | $1.45 |
| Market cap | $43.67M | $69.84M |
| 1-day change | -9.72% | -9.40% |
| YTD return | -70.17% | -57.62% |
| 1-year return | -83.86% | -62.47% |
| 5-year return | -95.10% | -65.92% |
| Forward P/E | — | 9.32 |
| EPS (TTM) | $-0.12 | $-0.52 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $151.82M | $194.06M |
| Revenue growth (YoY) | -15.82% | +25.34% |
| Net income (latest FY) | $-11.67M | $14.35M |
| Gross margin | 59.37% | 85.72% |
| Operating margin | -7.61% | -3.95% |
| Net margin | -7.68% | 7.40% |
| 52-week high | $5.79 | $5.38 |
| 52-week low | $0.516 | $1.38 |
| Distance from 52-week high | -89.80% | -73.14% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +661.81% | +462.63% |
| Average volume | 1.27M | 929.40K |
| Shares outstanding | 73.93M | 48.33M |
| Employees | 330 | 347 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- LFMD has outperformed AIRS by 21.4 percentage points over the past year.
- LifeMD is more profitable, keeping 7.4 cents of every revenue dollar as net income versus -7.7 cents for AirSculpt Technologies.
- LifeMD grew revenue faster in its latest fiscal year (+25.34% vs -15.82%).
About AirSculpt Technologies
AIRS stock →AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure.
Health Care · Medical/Nursing Services · 330 employees
About LifeMD
LFMD stock →LifeMD, Inc. operates as a direct-to-patient telehealth company, engages in the provision of patients access to virtual medical care and pharmacy services in the United States.
Health Care · Medical/Nursing Services · 347 employees
AIRS vs LFMD FAQ
Which is bigger, AirSculpt Technologies or LifeMD?
LifeMD (LFMD) is larger, with a market capitalization of $69.84M compared with $43.67M for AirSculpt Technologies (AIRS).
Which stock has performed better over the past year, AIRS or LFMD?
LFMD returned -62.47% over the past 12 months, compared with -83.86% for AIRS (price return, excluding dividends). Past performance does not predict future results.
Are AirSculpt Technologies and LifeMD in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.